StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Wednesday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.29 on Wednesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.25 and a current ratio of 0.89. China Pharma has a fifty-two week low of $0.27 and a fifty-two week high of $2.18. The firm has a 50 day moving average price of $0.34 and a 200-day moving average price of $0.43.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) earnings per share for the quarter. The business had revenue of $1.37 million during the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- How to invest in marijuana stocks in 7 stepsÂ
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- Golden Cross Stocks: Pattern, Examples and Charts
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
